Centene files lawsuit against Amerigroup
The lawsuit was filed in response to Amerigroup’s purported termination of its previously disclosed agreement to purchase certain assets of Centene’s New Jersey subsidiary, University Health Plans. Centene
Amberstone Biosciences has signed a partnership and licence agreement with Shanghai Henlius Biotech for conditionally activated T-cell engager candidates to treat solid tumours.